Immunovant Stock Market Value

IMVT -  USA Stock  

USD 8.21  0.09  1.08%

Immunovant's market value is the price at which a share of Immunovant stock trades on a public exchange. It measures the collective expectations of Immunovant investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Immunovant and determine expected loss or profit from investing in Immunovant over a given investment horizon. Please see Immunovant Hype Analysis, Immunovant Correlation, Immunovant Valuation, Immunovant Volatility, as well as analyze Immunovant Alpha and Beta and Immunovant Performance.

Is Immunovant's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunovant. If investors know Immunovant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunovant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunovant is measured differently than its book value, which is the value of Immunovant that is recorded on the company's balance sheet. Investors also form their own opinion of Immunovant's value that differs from its market value or its book value, called intrinsic value, which is Immunovant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunovant's market value can be influenced by many factors that don't directly affect Immunovant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunovant value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunovant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immunovant 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunovant's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunovant.
No Change 0.00  0.0 
In 11 months and 27 days
If you would invest  0.00  in Immunovant on October 30, 2020 and sell it all today you would earn a total of 0.00 from holding Immunovant or generate 0.0% return on investment in Immunovant over 360 days. Immunovant is related to or competes with Brickell Biotech, Bellus Health, Mustang Bio, Bridgebio Pharma, Brooklyn Immunotherapeuti, Moleculin Biotech, and Bioatla. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoim...

Immunovant Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunovant's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunovant upside and downside potential and time the market with a certain degree of confidence.

Immunovant Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunovant's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunovant's standard deviation. In reality, there are many statistical measures that can use Immunovant historical prices to predict the future Immunovant's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunovant's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunovant in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
8 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunovant. Your research has to be compared to or analyzed against Immunovant's peers to derive any actionable benefits. When done correctly, Immunovant's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunovant.

Immunovant Backtested Returns

Immunovant holds Efficiency (Sharpe) Ratio of -0.0632, which attests that the entity had -0.0632% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Immunovant exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Immunovant risk adjusted performance of (0.022726), and Market Risk Adjusted Performance of (0.35) to validate the risk estimate we provide.
The company retains a Market Volatility (i.e., Beta) of 0.5651, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Immunovant's beta means in this case. As returns on the market increase, Immunovant returns are expected to increase less than the market. However, during the bear market, the loss on holding Immunovant will be expected to be smaller as well. Even though it is essential to pay attention to Immunovant current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Immunovant exposes twenty-one different technical indicators, which can help you to evaluate its performance. Immunovant has an expected return of -0.28%. Please be advised to check out Immunovant coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Immunovant performance from the past will be repeated at some point in the near future.
AdviceVolatility TrendExposureCorrelations



Good predictability

Immunovant has good predictability. Overlapping area represents the amount of predictability between Immunovant time series from 30th of October 2020 to 28th of April 2021 and 28th of April 2021 to 25th of October 2021. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunovant price movement. The serial correlation of 0.74 indicates that around 74.0% of current Immunovant price fluctuation can be explain by its past prices.
Correlation Coefficient0.74
Spearman Rank Test0.79
Residual Average0.0
Price Variance7.13

Immunovant lagged returns against current returns

Autocorrelation, which is Immunovant stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunovant's stock expected returns. We can calculate the autocorrelation of Immunovant returns to help us make a trade decision. For example, suppose you find that Immunovant stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 

Immunovant regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunovant stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunovant stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunovant stock over time.
 Current vs Lagged Prices 

Immunovant Lagged Returns

When evaluating Immunovant's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunovant stock have on its future price. Immunovant autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunovant autocorrelation shows the relationship between Immunovant stock current value and its past values and can show if there is a momentum factor associated with investing in Immunovant.
 Regressed Prices 

Immunovant Investors Sentiment

The influence of Immunovant's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunovant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - IMVT

Immunovant Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunovant. What is your judgment towards investing in Immunovant? Are you bullish or bearish?
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunovant using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Immunovant Hype Analysis, Immunovant Correlation, Immunovant Valuation, Immunovant Volatility, as well as analyze Immunovant Alpha and Beta and Immunovant Performance. Note that the Immunovant information on this page should be used as a complementary analysis to other Immunovant's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Immunovant Stock analysis

When running Immunovant price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunovant technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunovant trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...